- Home
- DGICB vs LAB Comparison
DGICB vs LAB Comparison
Compare DGICB & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGICB
- LAB
- Stock Information
- Founded
- DGICB 1986
- LAB 1999
- Country
- DGICB United States
- LAB United States
- Employees
- DGICB N/A
- LAB N/A
- Industry
- DGICB Property-Casualty Insurers
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- DGICB Finance
- LAB Industrials
- Exchange
- DGICB Nasdaq
- LAB Nasdaq
- Market Cap
- DGICB 562.0M
- LAB 504.2M
- IPO Year
- DGICB N/A
- LAB 2011
- Fundamental
- Price
- DGICB $15.33
- LAB $1.24
- Analyst Decision
- DGICB
- LAB Buy
- Analyst Count
- DGICB 0
- LAB 2
- Target Price
- DGICB N/A
- LAB $2.50
- AVG Volume (30 Days)
- DGICB 838.0
- LAB 1.6M
- Earning Date
- DGICB 10-30-2025
- LAB 11-04-2025
- Dividend Yield
- DGICB 4.32%
- LAB N/A
- EPS Growth
- DGICB 219.92
- LAB N/A
- EPS
- DGICB 2.38
- LAB N/A
- Revenue
- DGICB $987,826,050.00
- LAB $172,271,000.00
- Revenue This Year
- DGICB $2.26
- LAB N/A
- Revenue Next Year
- DGICB $3.46
- LAB N/A
- P/E Ratio
- DGICB $7.72
- LAB N/A
- Revenue Growth
- DGICB 0.89
- LAB 76.33
- 52 Week Low
- DGICB $13.19
- LAB $0.92
- 52 Week High
- DGICB $20.46
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- DGICB 49.46
- LAB 45.85
- Support Level
- DGICB $15.33
- LAB $1.12
- Resistance Level
- DGICB $15.70
- LAB $1.25
- Average True Range (ATR)
- DGICB 0.24
- LAB 0.09
- MACD
- DGICB 0.08
- LAB -0.01
- Stochastic Oscillator
- DGICB 33.78
- LAB 34.29
About DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.